Department of Experimental and Clinical Biomedical Sciences "Mario Serio", Centre of Excellence DeNothe, University of Florence, Florence, Italy.
Andrology Department, Fundació Puigvert, Universitat Autònoma de Barcelona, Instituto de Investigaciones Biomédicas Sant Pau (IIB-Sant Pau), Barcelona, Catalonia, Spain.
Genet Med. 2019 Jan;21(1):189-194. doi: 10.1038/s41436-018-0037-1. Epub 2018 Jun 14.
In about 10% of patients affected by Fanconi anemia (FA) the diagnosis is delayed until adulthood, and the presenting symptom in these "occult" FA cases is often a solid cancer and cancer treatment-related toxicity. Highly predictive clinical parameter(s) for diagnosing such an adult-onset cases are missing.
(1) Exome sequencing (ES), (2) Sanger sequencing of FANCA, (3) diepoxybutane (DEB)-induced chromosome breakage test.
ES identified a pathogenic homozygous FANCA variant in a patient affected by Sertoli cell-only syndrome (SCOS) and in his azoospermic brother. Although they had no overt anemia, chromosomal breakage test revealed a reverse somatic mosaicism in the former and a typical FA picture in the latter. In 27 selected SCOS cases, 1 additional patient showing compound heterozygous pathogenic FANCA variants was identified with positive chromosomal breakage test.
We report an extraordinarily high frequency of FA in a specific subgroup of azoospermic patients (7.1%). The screening for FANCA pathogenic variants in such patients has the potential to identify undiagnosed FA before the appearance of other severe clinical manifestations of the disease. The definition of this high-risk group for "occult" FA, based on specific testis phenotype with mild/borderline hematological alterations, is of unforeseen clinical relevance.
约有 10%的范可尼贫血(FA)患者的诊断会延迟到成年期,这些“隐匿”FA 病例的首发症状通常是实体瘤和癌症治疗相关的毒性。目前缺乏用于诊断此类成年发病病例的高度预测性临床参数。
(1)外显子组测序(ES),(2)FANCA 的 Sanger 测序,(3)双环氧丁烷(DEB)诱导的染色体断裂试验。
ES 在一名患有唯支持细胞综合征(SCOS)和非梗阻性无精子症的患者及其无精症兄弟中鉴定出了致病性纯合 FANCA 变异。尽管他们没有明显的贫血,但染色体断裂试验显示前者存在逆向体体细胞镶嵌现象,后者则存在典型的 FA 图像。在 27 例精选的 SCOS 病例中,还发现了 1 例具有复合杂合致病性 FANCA 变异的患者,其染色体断裂试验呈阳性。
我们报告了在特定的无精子症患者亚组中存在极高频率的 FA(7.1%)。在这些患者中筛查 FANCA 致病性变异具有在出现其他严重疾病临床表现之前识别未诊断 FA 的潜力。基于轻度/临界血液学改变的特定睾丸表型来定义这种隐匿性 FA 的高危群体,具有意外的临床意义。